Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 2Lymphoma 2Subcutaneous panniculitis-like T-cell lymphoma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Extranodal NK-T-Cell 1Leukemia 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 12fludarabine 10fludarabine phosphate 7Radiotherapy 6Mycophenolic Acid 6Whole-Body Irradiation 5Sirolimus 5Filgrastim 5Tacrolimus 4Melphalan 4Busulfan 4Peripheral Blood Stem Cell Transplantation 3Methylprednisolone 3Cyclosporine 3Thiotepa 2Stem Cell Transplantation 2Specimen Handling 2Rituximab 2Methotrexate 2Mesna 2Granulocyte Colony-Stimulating Factor 2Etoposide 2venetoclax 1siplizumab 1rasburicase 1prostaglandin D2 receptor 1milatuzumab 1itacitinib 1eritoran 1Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Graft vs Host Disease × siplizumab × Clear all
NCT00806728 2008-12-11

Study of MEDI-507 in With Steroid-Resistant Acute Graft-Versus-Host Disease

MedImmune LLC

Phase 1 Completed
17 enrolled

Graft vs Host Disease, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡